Lifeward Ltd. (LFWD) Form 8-K — Oct 27, 2026

$LFWDForm 8-KItems 5.02Filed Oct 27, 2026, 8:55 AM ET0001178913-26-004856Original filing

Lifeward Ltd. (LFWD) appointed Ronen Tsimerman, 56, as Chief Financial Officer, principal financial officer, and principal accounting officer, effective November 1, 2026. Tsimerman is a veteran Israeli medtech finance executive, most recently CFO of Scopio Labs and previously CFO/COO of IceCure Medical (Nasdaq: ICCM) for over nine years. His employment agreement provides a gross monthly base salary of NIS 70,000 plus performance bonuses, subject to shareholder approval of a renewed compensation policy at the October 30, 2026 annual general meeting.

Key figures

Notice period months: 3
Target bonus minimum: not less than four monthly salaries
Cfo gross monthly base salary nis: 70000
Notice period after ceo change months: 4

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.